23 May 2013
Keywords: update, bristol-myers, squibb, looks, oncology, come-back, 430m
Article | 01 October 2007
Bristol-Myers Squibb, the US drug major that once dominated the oncology market with products such as Taxol (paclitaxel) is making ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 October 2007
27 September 2007
22 May 2013
© 2013 thepharmaletter.com